admin

The Pentagon is not backing down from its quest for consequences for those who celebrate Charlie Kirk’s killing, even as Democrats warn the move is ‘un-American’ and violates free speech protections. The controversy underscores a…

Former Sen. Joe Manchin, I-W.Va., wanted Republicans to win the Senate last year in order to prevent Democrats’ pursuit of ‘raw political power.’ In his new book, ‘Dead Center: In Defense of Common Sense,’ set…

As questions swirl about FBI Director Kash Patel’s leadership of the agency, particularly in the immediate hours after the assassination of Charlie Kirk, Senate Republicans appear ready to back him. Patel is due before the…

The gold sector is undergoing another wave of portfolio reshuffling. Fresh deals across the sector signal a growing shift toward consolidation and selective asset sales as stakeholders seek further growth during the yellow metal’s historic…

Alvopetro Energy Ltd. (TSXV: ALV,OTC:ALVOF) (OTCQX: ALVOF) announces that our Board of Directors has declared a quarterly dividend of US$0.10 per common share, payable in cash on October 15, 2025 to shareholders of record at…

US-China tensions are causing a shift in global gold market dynamics. Escalating trade tensions with the US have prompted China to take a defensive stance economically. This has become a major gold price driver in…

Here’s a quick recap of the crypto landscape for Monday (September 15) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.…

Brightstar Resources (BTR:AU) has announced Over 50% Q-o-Q Production Growth Targeted Download the PDF here. This post appeared first on investingnews.com

John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices in 2025. His next target for gold is US$3,800 per ounce, and he still expects US$50 per ounce…

lobe sciences ltd. (CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F) (‘Lobe Sciences’ or the ‘Company’) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation…